[1]
2023. Comparison of Drug Regimens (Sofosbuvir and velpatasvir versus Sofosbuvir and Daclatasvir) in Treatment of Chronic Hepatitis C Virus Patients in Terms of Efficacy and Safety . Medical Forum Monthly. 34, 10 (Nov. 2023). DOI:https://doi.org/10.60110/medforum.341023.